[{"Assets_0_Q2_USD":106717000.0,"CommonStockSharesOutstanding_0_Q2_shares":25785000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-28260000.0,"NetIncomeLoss_1_Q2_USD":-20601000.0,"NetIncomeLoss_2_Q2_USD":-39803000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":24999000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":48084000.0,"StockholdersEquity_0_Q2_USD":8618000.0,"Ticker":"NSTG","CIK":"1401708","name":"NANOSTRING TECHNOLOGIES INC","OfficialName":"NanoString Technologies Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"995164151.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20180808"}]